Sarah K. Johnson, Ph.D.


Research Assistant Professor, Department of PathologyPh.D., Department of Biochemistry and Molecular Biology, University of Arkansas forJohnsonSarahK Medical Sciences, Little Rock, AR
Post-doctoral Fellowship, Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC

Selected Publications:

Johnson SK, Haun RS. Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth. World J Gastroenterol 2009; 15(27): 3355-3366. PMID: 19610136

Wei Xiong, Xiaosong Wu, Sarah Starnes, Sarah K. Johnson, Jeff Haessler, Siqing Wang, Lijuan Chen, Bart Barlogie, John D. Shaughnessy, Jr, and Fenghuang Zhan.  An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood, 15 November 2008, Vol. 112, No. 10, pp. 4235-4246

Johnson Sarah K., Vishnu P. Ramani, Laura W. Lamps and Randy S. Haun.  Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer, 2007; 109:1811-1820.

Johnson Sarah K., Richard Dennis, Laura W. Lamps and Randy S. Haun. Differential Expression of Insulin-like Growth Factor Binding Protein 5 in Pancreatic Adenocarcinomas: Identification Using DNA Microarray. Mol Carcinog 2006; 45: 814–827.

Sarah K Johnson and Randy S Haun. The Gamma-Aminobutyric Acid A Receptor π Subunit Is Overexpressed in Pancreatic Adenocarcinomas.  J Pancreas (Online) 2005; 6(2):6001-6007.

Ray A. Lebeda, Sarah K. Johnson, Malcolm I. Stewart, and Randy S. Haun. Sequence, genomic organization, and expression of the human ADP-ribosylation factor 6 (ARF6) gene: a class III ARF. DNA and Cell Biology, 22 (11), 737-741, 2003.